MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 134 filers reported holding MERSANA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,173 | -61.4% | 17,459 | 0.0% | 0.00% | – |
| Q2 2023 | $57,440 | +14.1% | 17,459 | +42.6% | 0.00% | – |
| Q1 2023 | $50,335 | -29.9% | 12,247 | 0.0% | 0.00% | – |
| Q4 2022 | $71,767 | +46.5% | 12,247 | +68.6% | 0.00% | – |
| Q3 2022 | $49,000 | +44.1% | 7,262 | 0.0% | 0.00% | – |
| Q2 2022 | $34,000 | +17.2% | 7,262 | 0.0% | 0.00% | – |
| Q1 2022 | $29,000 | -52.5% | 7,262 | -26.1% | 0.00% | – |
| Q4 2021 | $61,000 | -35.8% | 9,826 | -2.6% | 0.00% | -100.0% |
| Q3 2021 | $95,000 | -30.7% | 10,092 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $137,000 | -14.9% | 10,081 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $161,000 | -16.6% | 9,947 | +37.0% | 0.00% | 0.0% |
| Q4 2020 | $193,000 | +82.1% | 7,262 | +28.0% | 0.00% | 0.0% |
| Q3 2020 | $106,000 | -20.3% | 5,674 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $133,000 | – | 5,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |